| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Breast 3D model as a possible tool for non-invasive tumour localization in breast surgery
|
Gouveia, P.
|
|
|
138 |
S1 |
p. S77-S78
|
artikel
|
| 2 |
Accuracy of Magnetic Localisation device placement and retrieval in breast cancer patients from a single internationally Accredited Breast Centre in Johannesburg South Africa
|
Benn, C.
|
|
|
138 |
S1 |
p. S43
|
artikel
|
| 3 |
A dedicated osteoporosis service improves bone health standards for aromatase inhibitor associated bone loss in Breast Cancer patients
|
Bell, A.
|
|
|
138 |
S1 |
p. S112
|
artikel
|
| 4 |
Administration of LHRH agonist as an adjuvant endocrine therapy for breast cancer is a risk factor of ovarian function recovery after switching from tamoxifen to aromatase inhibitor
|
Ishige, H.
|
|
|
138 |
S1 |
p. S55
|
artikel
|
| 5 |
Advancing the age limit for core biopsy for U2 ultrasound lesions – are we ready?
|
Kasturi, C.Ruwan
|
|
|
138 |
S1 |
p. S121
|
artikel
|
| 6 |
Age-, community-matched Body Mass Index and overall survival in patients with breast cancers
|
Lee, J.
|
|
|
138 |
S1 |
p. S81
|
artikel
|
| 7 |
A high rate of pathological complete response is possible by incorporating cisplatin in neoadjuvant therapy of locally advanced triple-negative breast cancer: A single-institution experience
|
Georgy, J.
|
|
|
138 |
S1 |
p. S60
|
artikel
|
| 8 |
A human-derived acellular dermal matrix for breast reconstruction: The first European experience
|
Marongiu, F.
|
|
|
138 |
S1 |
p. S42
|
artikel
|
| 9 |
Aim and Scope
|
|
|
|
138 |
S1 |
p. iii
|
artikel
|
| 10 |
Analysis of fractal dimension allows identification of malignancies in breast tissue histopathological images
|
da Silva, L.G.
|
|
|
138 |
S1 |
p. S105
|
artikel
|
| 11 |
An audit of chemoprevention provision in a breast cancer family history clinic
|
Patel, A.
|
|
|
138 |
S1 |
p. S81
|
artikel
|
| 12 |
An exploratory phase II study of Eribulin re-challenge after short term therapy of 5-fuluorouracil for HER2-negative, advanced or recurrent breast cancer
|
Takashima, T.
|
|
|
138 |
S1 |
p. S62
|
artikel
|
| 13 |
Angiosome theory findings using new protocol of CT-angiography improves outcomes in DIEP-flap reconstruction surgery in breast cancer patients
|
Pesotsky, R.
|
|
|
138 |
S1 |
p. S24
|
artikel
|
| 14 |
A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer
|
Beek, M.
|
|
|
138 |
S1 |
p. S33
|
artikel
|
| 15 |
APOBEC driving genomic evolution in ER+/HER2- breast cancer
|
Bos, M.
|
|
|
138 |
S1 |
p. S105-S106
|
artikel
|
| 16 |
Application of ACOSOG Z0011 patient selection criteria to an Indian breast cancer cohort undergoing sentinel lymph node biopsy
|
Goel, A.K.
|
|
|
138 |
S1 |
p. S115-S116
|
artikel
|
| 17 |
Application of culture-based assays to human malignant breast tissue can infer tumour microbiota composition
|
Hogan, G.
|
|
|
138 |
S1 |
p. S78
|
artikel
|
| 18 |
A prospective analysis of patient-reported outcomes within breast cancer surgical treatment strategies
|
Oemrawsingh, A.
|
|
|
138 |
S1 |
p. S109
|
artikel
|
| 19 |
A Randomised Controlled Trial (RCT) of 3-dimensional simulation of the aesthetic outcome of Breast Conserving Treatment (BCT)
|
Godden, A.
|
|
|
138 |
S1 |
p. S32
|
artikel
|
| 20 |
A review of localization techniques in breast surgery – is wire free the future?
|
Norman, C.
|
|
|
138 |
S1 |
p. S117
|
artikel
|
| 21 |
A review of subsequent breast cancers detected on mammographic surveillance following Vacuum Assisted Excision for lesions of uncertain malignant potential (B3) with atypia
|
Sweeney, L.
|
|
|
138 |
S1 |
p. S109-S110
|
artikel
|
| 22 |
Assessing the benefits and toxicities of platinum containing neoadjuvant chemotherapy in triple negative breast cancer
|
Jarral, K.
|
|
|
138 |
S1 |
p. S57
|
artikel
|
| 23 |
Association of axillary lymph node evaluation with survival in women aged 70 years or older with breast cancer
|
Luo, S.
|
|
|
138 |
S1 |
p. S27
|
artikel
|
| 24 |
Association of genetic variations for prediction of hot flushes in women taking tamoxifen for breast cancer prevention
|
Hale, M.
|
|
|
138 |
S1 |
p. S15
|
artikel
|
| 25 |
Association of germline genetic variants with breast cancer survival in patient subgroups defined by standard clinic-pathological variables
|
Morra, A.
|
|
|
138 |
S1 |
p. S79
|
artikel
|
| 26 |
Audit of surgical de-escalation following revised UK guidelines for margins and completion axillary clearance at a single UK teaching hospital
|
Nayak, S.
|
|
|
138 |
S1 |
p. S116
|
artikel
|
| 27 |
Author index
|
|
|
|
138 |
S1 |
p. S125-S137
|
artikel
|
| 28 |
Automatic detection of perforators for microsurgical reconstruction and correlation with patient’s body-mass index
|
Pinto, D.
|
|
|
138 |
S1 |
p. S51
|
artikel
|
| 29 |
Axillary lymph node involvement may be predicted by breast cancer subtype: a single center experience
|
Cisternino, G.
|
|
|
138 |
S1 |
p. S74-S75
|
artikel
|
| 30 |
Axillary management in patients with breast cancer and positive axilla at diagnosis
|
Gomez, M.Jimenez
|
|
|
138 |
S1 |
p. S43
|
artikel
|
| 31 |
Axillary staging with supine 18F-FDG PET/CT is useful in breast cancer patients undergoing tailored axillary treatment after neoadjuvant systemic therapy according to the MARI protocol
|
Van Loevezijn, A.
|
|
|
138 |
S1 |
p. S49
|
artikel
|
| 32 |
Blood group and save samples for elective breast surgery: An unnecessary cost?
|
Chouari, T.
|
|
|
138 |
S1 |
p. S49-S50
|
artikel
|
| 33 |
BluePrint molecular subtyping recognizes single and dual subtype tumors with consequences for therapeutic guidance
|
Kuilman, M.
|
|
|
138 |
S1 |
p. S106-S107
|
artikel
|
| 34 |
BRCA screening among Jewish community of Rome
|
De Marchis, L.
|
|
|
138 |
S1 |
p. S80-S81
|
artikel
|
| 35 |
BRCA variant classification of ClinVar submitter content from ENIGMA, ARUP laboratories and German cancer consortium compared to MH BRCA® and correlation with response to PARP inhibition in MH GUIDE®
|
Stecker, K.
|
|
|
138 |
S1 |
p. S77
|
artikel
|
| 36 |
Breast cancer among immigrants: An Irish experience
|
Weadick, C.
|
|
|
138 |
S1 |
p. S104-S105
|
artikel
|
| 37 |
Breast cancer community screening in low resource settings: Lessons from Pune, India
|
Busheri, L.
|
|
|
138 |
S1 |
p. S69
|
artikel
|
| 38 |
Breast cancer in elderly patients: are we choosing wisely? A critical review of the breast unit of Trieste
|
Giudici, F.
|
|
|
138 |
S1 |
p. S32-S33
|
artikel
|
| 39 |
Breast cancer patients undergoing delayed deep inferior epigastric perforator (DIEP) flap reconstruction differ from their matched controls by a higher socioeconomic status and better overall survival
|
Adam, H.
|
|
|
138 |
S1 |
p. S95
|
artikel
|
| 40 |
Breast cancer patients with leptomeningeal carcinomatosis: Treatment results and validation of prognostic indexes
|
Ratosa, I.
|
|
|
138 |
S1 |
p. S65
|
artikel
|
| 41 |
Breast Cancer Screening in undeveloped country. How precision medicine will help?
|
Fatima, A.
|
|
|
138 |
S1 |
p. S98
|
artikel
|
| 42 |
Breast conserving surgery in breast cancer after neoadjuvant chemotherapy – opportunity of radioopaque tumor marking clips
|
Iancu, G.
|
|
|
138 |
S1 |
p. S36-S37
|
artikel
|
| 43 |
Breast-conserving surgery under local anaesthesia is a safe and effective option for local control in an increasingly frail population
|
Bell, A.
|
|
|
138 |
S1 |
p. S118
|
artikel
|
| 44 |
Breast incidentalomas. How often do they are? – A 5-year Greek hospital experience
|
Mitrousias, A.
|
|
|
138 |
S1 |
p. S99-S100
|
artikel
|
| 45 |
Breast Lesion Excision System as a treatment method for small invasive breast cancers
|
Sanderink, W.
|
|
|
138 |
S1 |
p. S26-S27
|
artikel
|
| 46 |
Breast referral management and outcome during COVID 19 Pandemic – A UK experience
|
Noor, L.
|
|
|
138 |
S1 |
p. S121
|
artikel
|
| 47 |
Change in trend in various clinico-pathological factors and treatment profile of breast cancer patients in developing countries: A tertiary cancer center experience
|
Sharma, S.
|
|
|
138 |
S1 |
p. S93
|
artikel
|
| 48 |
Characteristics and clinical outcome of breast cancer patients with asymptomatic brain metastases
|
Laakmann, E.
|
|
|
138 |
S1 |
p. S19
|
artikel
|
| 49 |
Characteristics of ipsilateral breast tumor recurrence after breast conserving surgery: Single center experience
|
Lee, H.
|
|
|
138 |
S1 |
p. S21
|
artikel
|
| 50 |
Characteristics of metastatic breast cancer patients obtaining a clinical complete response with systemic therapies
|
Horimoto, Y.
|
|
|
138 |
S1 |
p. S62-S63
|
artikel
|
| 51 |
Characterization of 331G/A polymorphism of rp gene and identification of viral oncogene HMTV virus as genetic markers for the improvement of breast cancer management in Cameroon
|
Kaze, N.Nguedia
|
|
|
138 |
S1 |
p. S78
|
artikel
|
| 52 |
Chemoprevention for breast cancer: A survey of the views of Australian women and clinicians
|
Macdonald, C.
|
|
|
138 |
S1 |
p. S8
|
artikel
|
| 53 |
Chronic toxicity after intraoperative electron radiotherapy as boost followed by whole breast irradiation
|
Oses, G.
|
|
|
138 |
S1 |
p. S84
|
artikel
|
| 54 |
Circulating tumor associated cells in breast cancers are resistance educated towards prior anthracycline treatments
|
Srinivasan, A.
|
|
|
138 |
S1 |
p. S76
|
artikel
|
| 55 |
Circulating tumour DNA as a prognostic biomarker in predicting breast cancer outcomes: Systematic review and meta-analysis
|
Cullinane, C.
|
|
|
138 |
S1 |
p. S96
|
artikel
|
| 56 |
Clinical correlation between Programmed Cell Death Ligand One (PD L-1) Expression, Tumor Infiltrating Lymphocytes (TILs) and pathological response of locally advanced Human Epidermal Receptor (HER 2) & Triple Negative (TN) Breast Cancer (BC) Egyptian patients undergoing neoadjuvant Therapy
|
Shash, E.
|
|
|
138 |
S1 |
p. S73
|
artikel
|
| 57 |
Clinical decision trees provide a means for systematic registration and evaluation of multidisciplinary team recommendations
|
Hendriks, M.
|
|
|
138 |
S1 |
p. S51-S52
|
artikel
|
| 58 |
Clinical, imaging and pathology factors related to residual axillary disease after neoadjuvant treatment
|
Vernet-Tomas, M.
|
|
|
138 |
S1 |
p. S34-S35
|
artikel
|
| 59 |
Clinical pathological association with breast cancer gene analysis through next generation sequencing
|
Jung, S.
|
|
|
138 |
S1 |
p. S79
|
artikel
|
| 60 |
Clinical prediction models for patients diagnosed with breast cancer: A systematic review
|
Hueting, T.
|
|
|
138 |
S1 |
p. S96
|
artikel
|
| 61 |
Clinical significance of the failure of sentinel lymph node mapping in patients with non-advanced invasive breast cancer – single-centre analysis
|
Nowikiewicz, T.
|
|
|
138 |
S1 |
p. S114-S115
|
artikel
|
| 62 |
Clinical utility of MammaPrint testing in Invasive Lobular Carcinoma: Results from the MINDACT phase III trial
|
Metzger, O.
|
|
|
138 |
S1 |
p. S5-S6
|
artikel
|
| 63 |
Cluster randomised trial to evaluate the clinical benefits of decision support interventions for older women with operable breast cancer
|
Wyld, L.
|
|
|
138 |
S1 |
p. S7
|
artikel
|
| 64 |
Combined iodinated radiographic contrast and Tc99 radioisotope (i-ROLL) as technical improvement for the preoperative localization of non-palpable breast lesions: A comparative study with ROLL
|
Ferrer, M.Medarde
|
|
|
138 |
S1 |
p. S25-S26
|
artikel
|
| 65 |
Communication of biopsy results: A breast radiologist task?
|
Vitale, V.A.
|
|
|
138 |
S1 |
p. S98-S99
|
artikel
|
| 66 |
Comparative accuracy of preoperative tumour size of invasive ductal carcinoma on Magnetic Resonance Imaging, Digital Breast Tomosynthesis, Ultrasound and Computed Tomography: Radiologicpathologic incongruence and clinical implications
|
Parab, A.V.
|
|
|
138 |
S1 |
p. S38
|
artikel
|
| 67 |
Compared expression of Tumour Infiltrating Lymphocytes and FOXA1 in matched pairs of brain metastasis and primary breast cancer and prognostic implications – a pilot study
|
Thulin, A.
|
|
|
138 |
S1 |
p. S63-S64
|
artikel
|
| 68 |
Compliance to adjuvant endocrine treatment – real world data from 1019 consecutive luminal breast cancer patients with long follow-up
|
Chamalidou, C.
|
|
|
138 |
S1 |
p. S59
|
artikel
|
| 69 |
Computerized scoring tool for identification and quantification of different immune cell populations in breast tumor regions
|
Berben, L.
|
|
|
138 |
S1 |
p. S71
|
artikel
|
| 70 |
Contemporary picture of metastatic breast cancer: Characteristics and outcomes of 22,000 women from the ESME cohort 2008–2016
|
Deluche, E.
|
|
|
138 |
S1 |
p. S4
|
artikel
|
| 71 |
Contralateral breast cancer in patients with ductal carcinoma in situ and invasive breast cancer in the Netherlands
|
Giardiello, D.
|
|
|
138 |
S1 |
p. S12
|
artikel
|
| 72 |
Correlation of ultrasound elastography of breast lesions with histopathology and immunohistochemistry: Looking for prognostic significance
|
Sharma, S.
|
|
|
138 |
S1 |
p. S119
|
artikel
|
| 73 |
Cosmetic outcome and symmetry for patients who have undergone bilateral therapeutic mammoplasty for breast cancer
|
Gulis, K.
|
|
|
138 |
S1 |
p. S33
|
artikel
|
| 74 |
Cost-effectiveness of digital mammography screening in the Netherlands: An extensive evaluation of 920 strategies
|
Kregting, L.
|
|
|
138 |
S1 |
p. S99
|
artikel
|
| 75 |
Cost-effective strategies according to the first randomized trial comparing MRI breast cancer screening with mammography in women with a familial risk: FaMRIsc
|
Tilanus-Linthorst, M.
|
|
|
138 |
S1 |
p. S2
|
artikel
|
| 76 |
Cryotherapy to prevent doxorubicin-associated oral mucositis
|
Brink-Mosch, L.
|
|
|
138 |
S1 |
p. S52
|
artikel
|
| 77 |
Current clinical practice and determinants of the use of delayed breast reconstruction in the Netherlands
|
Van Egdom, P.
|
|
|
138 |
S1 |
p. S34
|
artikel
|
| 78 |
Current status for breast density notification in Japan
|
Takahashi, H.
|
|
|
138 |
S1 |
p. S98
|
artikel
|
| 79 |
Cyclin-dependent kinase 4/6 inhibitors palbociclib or ribociclib combined with endocrine therapy and radiation therapy for patients with metastatic breast cancer
|
Ratosa, I.
|
|
|
138 |
S1 |
p. S66
|
artikel
|
| 80 |
Deep learning enables fully automated mitotic density assessment in breast cancer histopathology
|
Balkenhol, M.
|
|
|
138 |
S1 |
p. S86
|
artikel
|
| 81 |
Defining a “dedicated” breast cancer team
|
Maliko, N.
|
|
|
138 |
S1 |
p. S40
|
artikel
|
| 82 |
Definitive treatment of premalignant lesions of the breast with “double crown”: An innovative percutaneous technique
|
Aparicio, O.
|
|
|
138 |
S1 |
p. S51
|
artikel
|
| 83 |
Determinants of mammographic density change
|
Azam, S.
|
|
|
138 |
S1 |
p. S13
|
artikel
|
| 84 |
Determinants of non-participation in population-based breast cancer screening: a systematic review and meta-analysis
|
Ding, L.
|
|
|
138 |
S1 |
p. S2
|
artikel
|
| 85 |
Development of a multiplexed protein panel using a targeted proteomics approach for the study of CDK4/6 inhibitors resistance in hormone receptor positive breast cancer
|
Zurawska, M.
|
|
|
138 |
S1 |
p. S120
|
artikel
|
| 86 |
Development of an information standard for breast cancer in the Netherlands
|
Verloop, J.
|
|
|
138 |
S1 |
p. S22
|
artikel
|
| 87 |
Development of a qPCR based ER signaling pathway activity test predictive for response to endocrine therapy in ER IHC positive breast cancer patients
|
Pierik, A.
|
|
|
138 |
S1 |
p. S88-S89
|
artikel
|
| 88 |
Diagnostic performance of noninvasive imaging for assessment of axillary pathologic complete response after neoadjuvant systemic therapy in clinically node-positive breast cancer: A systematic review and meta-analysis
|
Samiei, S.
|
|
|
138 |
S1 |
p. S61
|
artikel
|
| 89 |
Diagnostic work-up in women suspect for breast cancer in the Netherlands
|
Siesling, S.
|
|
|
138 |
S1 |
p. S87
|
artikel
|
| 90 |
Did the BOOG 2013–08, which examines the value of omission of the sentinel lymph node in cT1-2 breast cancer treated with BCT, induce a change in axillary staging and treatment?
|
Colier, E.
|
|
|
138 |
S1 |
p. S47
|
artikel
|
| 91 |
Dietary acid load and breast cancer risk: A case-control study in Uruguay
|
Ronco, A.
|
|
|
138 |
S1 |
p. S122
|
artikel
|
| 92 |
Differences in breast cancer risk after a benign breast disease according to the screening type
|
Louro, J.
|
|
|
138 |
S1 |
p. S11
|
artikel
|
| 93 |
Differential impact of prognostic parameters in hormone receptor-positive lobular early breast cancer in the WSG PlanB trial
|
Christgen, M.
|
|
|
138 |
S1 |
p. S1
|
artikel
|
| 94 |
Direct or delayed oncoplastic reconstruction after wide local excision for breast cancer in breast conserving therapy: A single centre cohort study of 252 cases
|
Geluk, C.S.
|
|
|
138 |
S1 |
p. S48-S49
|
artikel
|
| 95 |
Distress and effectiveness of Brief Cognitive Behaviour Intervention for patients with family history of cancer
|
Srivastava, J.
|
|
|
138 |
S1 |
p. S54
|
artikel
|
| 96 |
Do clinical trials truly mirror their target population? An external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel node micrometastases in breast cancer
|
Andersson, Y.
|
|
|
138 |
S1 |
p. S36
|
artikel
|
| 97 |
Does concomitant DCIS affect the clinical outcome in breast cancer patients with invasive ductal carcinoma: An Asian perspective
|
Lee, W.P.
|
|
|
138 |
S1 |
p. S95
|
artikel
|
| 98 |
Does mesh improve patient satisfaction and health-related quality of life after implant-based breast reconstruction? A multicentre prospective cohort study
|
Sewart, E.
|
|
|
138 |
S1 |
p. S18-S19
|
artikel
|
| 99 |
Does Neo-adjuvant chemotherapy response in the primary breast tumour correlate with axillary response in proven node positive ER positive HER2 negative disease?
|
Borkar, N.
|
|
|
138 |
S1 |
p. S63
|
artikel
|
| 100 |
Do patients with breast cancer receive the optimal personalized follow up?
|
Van Hoeve, J.
|
|
|
138 |
S1 |
p. S21-S22
|
artikel
|
| 101 |
Dosimetric impact of an AI-based delineation software satisfying international guidelines in breast cancer radiotherapy
|
Ung, M.
|
|
|
138 |
S1 |
p. S113
|
artikel
|
| 102 |
Do surgical margins matter after mastectomy? A systematic review and meta-analysis
|
Bundred, J.
|
|
|
138 |
S1 |
p. S42
|
artikel
|
| 103 |
Dynamic monitoring of CD45-/CD31+/DAPI+ circulating endothelial cells aneuploid for chromosome 8 during neoadjuvant chemotherapy in locally advanced breast cancer
|
Ma, G.
|
|
|
138 |
S1 |
p. S55-S56
|
artikel
|
| 104 |
Early invasive ductal breast cancer: Review after 5-year median follow-up of the first 681 patients treated by partial breast irradiation with intraoperative electron radiation therapy
|
Philippson, C.
|
|
|
138 |
S1 |
p. S84
|
artikel
|
| 105 |
EDITORIAL BOARD
|
|
|
|
138 |
S1 |
p. ii
|
artikel
|
| 106 |
Effect of the COVID-19 pandemic on use of bone-modifying agents for metastatic breast cancer in a UK Oncology centre
|
Wang, L.
|
|
|
138 |
S1 |
p. S102
|
artikel
|
| 107 |
Effects of adjuvant breast radiotherapy delivered over one week (+/− sequential hypofractionated tumour bed boost): Prospective observational study confirming acceptable acute skin toxicity
|
Nugent, K.
|
|
|
138 |
S1 |
p. S113
|
artikel
|
| 108 |
Effects of cancer screening restart strategies after COVID-19 disruption
|
Kregting, L.
|
|
|
138 |
S1 |
p. S16
|
artikel
|
| 109 |
Effects of chemotherapy on serum lipids in Chinese postoperative breast cancer patients
|
Zhu, Y.
|
|
|
138 |
S1 |
p. S57
|
artikel
|
| 110 |
Effects of COVID-19 pandemics in a Breast unit
|
Kiziltan, G.
|
|
|
138 |
S1 |
p. S116
|
artikel
|
| 111 |
Effects of organised mammography screening on breast cancer care in specialist breast units in Aachen, Germany since 2008
|
Spelsberg, A.
|
|
|
138 |
S1 |
p. S111-S112
|
artikel
|
| 112 |
Efficacy and safety of eribulin in combination with trastuzumab in HER2-positive metastatic breast cancer patients: Real life experience
|
Kovalenko, E.
|
|
|
138 |
S1 |
p. S59
|
artikel
|
| 113 |
Efficacy and safety of neoadjuvant pertuzumab, trastuzumab and chemotherapy in non-metastatic HER2-positive breast cancer in the Asian population: a multicentre analysis
|
Chan, W.L.W.
|
|
|
138 |
S1 |
p. S123-S124
|
artikel
|
| 114 |
Endofascial axillary dissection – a novel method to reduce seroma formation
|
Srinidhi, M.
|
|
|
138 |
S1 |
p. S47
|
artikel
|
| 115 |
Enhanced axillary assessment using contrast enhanced ultrasound (CEUS) before neo-adjuvant systemic therapy (NACT) in breast cancer patients identifies axillary disease missed by conventional B-mode ultrasound that may be clinically relevant
|
Cox, K.
|
|
|
138 |
S1 |
p. S89
|
artikel
|
| 116 |
Epidemiological characteristics of invasive lobular carcinoma of the breast in North Africa: Example of a Tunisian population
|
Hadoussa, M.
|
|
|
138 |
S1 |
p. S50-S51
|
artikel
|
| 117 |
ESR1 mutations in metachronous contralateral breast cancer
|
Velthuisen, D.
|
|
|
138 |
S1 |
p. S124
|
artikel
|
| 118 |
Estimating lung cancer and cardiovascular mortality in female breast cancer patients receiving radiotherapy
|
Mulliez, T.
|
|
|
138 |
S1 |
p. S83
|
artikel
|
| 119 |
Evaluation of circulating cell-free DNA and its integrity as a potential predictive biomarker of breast cancer onset: A pilot study
|
Scaggiante, B.
|
|
|
138 |
S1 |
p. S71-S72
|
artikel
|
| 120 |
Evaluation of FES (16α-[18F]-fluoro-17β-estradiol) PET for (re)staging of patients with clinical (locally) advanced or locoregional recurrent estrogen receptor positive breast cancer
|
Iqbal, R.
|
|
|
138 |
S1 |
p. S88
|
artikel
|
| 121 |
Evaluation of FISH of ER-positive breast cancer with low-HER2 expression could improve their survival
|
Higuchi, T.
|
|
|
138 |
S1 |
p. S95
|
artikel
|
| 122 |
Evaluation of optimal prophylactic antiemetic regimens for doxorubicin-cyclophosphamide chemotherapy
|
Yeo, W.
|
|
|
138 |
S1 |
p. S123
|
artikel
|
| 123 |
Evaluation of synthesized 2D mammography visibility with same pixel pitch as full-field digital mammography
|
Furuya, Y.
|
|
|
138 |
S1 |
p. S97
|
artikel
|
| 124 |
Evaluation of the breast lesion excision system, a percutaneous, vacuum assisted, intact-specimen, breast biopsy device
|
Kinoglou, G.
|
|
|
138 |
S1 |
p. S30
|
artikel
|
| 125 |
Evaluation of the use of primary and hospital care in long-term breast cancer survivors: A longitudinal study based on real-world data
|
Jansana, A.
|
|
|
138 |
S1 |
p. S90-S91
|
artikel
|
| 126 |
Evolving psychosocial, emotional, functional, and support needs of women with advanced breast cancer (ABC) in Asia and Middle East (ME): Results from the Count Us, Know Us, Join Us (CUKUJU) survey
|
Ripley, A.
|
|
|
138 |
S1 |
p. S64
|
artikel
|
| 127 |
Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophageal doses published 2013–2018
|
Duane, F.
|
|
|
138 |
S1 |
p. S83-S84
|
artikel
|
| 128 |
Factors affecting locoregional recurrence rate of breast conserving surgery in patients with neoadjuvant chemotherapy
|
Chung, W.S.
|
|
|
138 |
S1 |
p. S96
|
artikel
|
| 129 |
Fatigue among long-term breast cancer survivors: a controlled cross-sectional study
|
Maass, S.
|
|
|
138 |
S1 |
p. S1-S2
|
artikel
|
| 130 |
Fatty acid inhibition reduces MYC expression in triple-negative breast cancer
|
Sritharan, N.
|
|
|
138 |
S1 |
p. S108
|
artikel
|
| 131 |
Fear of death among young breast cancer patients during adjuvant endocrine therapy
|
Luz, P.
|
|
|
138 |
S1 |
p. S122
|
artikel
|
| 132 |
Feasibility and comparison study of augmented breast self examination vs. conventional breast self examination rural Indian women for early detection- results of POC study
|
Vaddeboina, N.
|
|
|
138 |
S1 |
p. S97
|
artikel
|
| 133 |
Feasibility trial of lymph node marking using both clip and carbon dye in cN1 patients submitted to neo-adjuvant chemotherapy to improve accuracy of axillary surgical staging in ycN0 patients after treatment
|
Pinto, D.
|
|
|
138 |
S1 |
p. S115
|
artikel
|
| 134 |
Finding existing drugs potentially active against BRCA-mutated breast cancers: A literature-based approach
|
Crispino, S.
|
|
|
138 |
S1 |
p. S55
|
artikel
|
| 135 |
Five-year follow-up results of aerobic and circuit training on bone mineral density in early breast cancer patients
|
Blomqvist, C.
|
|
|
138 |
S1 |
p. S81
|
artikel
|
| 136 |
Frequency and spectrum of mutations in the BRCA1, BRCA2, PALB2, P53, PTEN, CHEK2, CDH1 genes in women from 3 cities of Colombia
|
Mejia, A.
|
|
|
138 |
S1 |
p. S110-S111
|
artikel
|
| 137 |
Gene expression profiles in premenopausal women with HR+ HER2− early breast cancer
|
Ni, H.
|
|
|
138 |
S1 |
p. S76
|
artikel
|
| 138 |
Genetic variability of PON1 and NT-proBNP levels after breast cancer radiotherapy
|
Marinko, T.
|
|
|
138 |
S1 |
p. S107
|
artikel
|
| 139 |
Genome wide association study of acute radiation toxicity and quality of life in breast cancer patients – results from the REQUITE cohort study
|
Rattay, T.
|
|
|
138 |
S1 |
p. S12
|
artikel
|
| 140 |
Getting fit for surgery: Introducing a multi-modal prehabilitation programme for our breast surgical patients
|
Wu, F.
|
|
|
138 |
S1 |
p. S82
|
artikel
|
| 141 |
Good cosmetic outcome after vacuum assisted excision of benign breast lesions
|
Van De Voort, E.
|
|
|
138 |
S1 |
p. S26
|
artikel
|
| 142 |
Gut microbial short chain fatty acids are associated with pathological complete response (pCR) after neoadjuvant chemotherapy for breast cancer
|
Ross, K.
|
|
|
138 |
S1 |
p. S20
|
artikel
|
| 143 |
High likelihood of actionable pathogenic variant detection in breast cancer genes in women with very early onset breast cancer, but low rate of additional panel genes
|
Evans, G.
|
|
|
138 |
S1 |
p. S1
|
artikel
|
| 144 |
HLX02, a China-manufactured trastuzumab biosimilar versus EU-sourced trastuzumab: Results of a global phase 3, randomized, double-blind efficacy and safety comparative study in metastatic breast cancer
|
Xu, B.
|
|
|
138 |
S1 |
p. S68
|
artikel
|
| 145 |
Hospital variation in the use of Sentinel Lymph Node Biopsy for patients with a biopsy diagnosis of ductal carcinoma in situ
|
Meurs, C.
|
|
|
138 |
S1 |
p. S30-S31
|
artikel
|
| 146 |
How I do it: Lymphatic mapping and sentinel lymph node biopsy with Indocianine Green in Breast Cancer patients, a prospective trial experience
|
York, E.
|
|
|
138 |
S1 |
p. S28
|
artikel
|
| 147 |
How many sentinel lymph nodes in addition to the clipped node are needed to accurately stage the axilla after neoadjuvant treatment in breast cancer?
|
Siso, C.
|
|
|
138 |
S1 |
p. S47-S48
|
artikel
|
| 148 |
Hypofractionated boost to the tumor bed in early breast cancer: Skin toxicity analysis
|
Oses, G.
|
|
|
138 |
S1 |
p. S83
|
artikel
|
| 149 |
Imaging and clinical predictors for nipple-areola complex (NAC) involvement in breast cancer patients undergoing Nipple-Sparing Mastectomy (NSM)
|
Lerena, I.Cebrecos
|
|
|
138 |
S1 |
p. S118
|
artikel
|
| 150 |
Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: A retrospective exploratory analysis of the BALLET study
|
Corona, S.
|
|
|
138 |
S1 |
p. S67
|
artikel
|
| 151 |
Impact of CDK4 knock out using CRISPR/Cas9 gene editing technology on breast cancer progression
|
Ahmed, A.
|
|
|
138 |
S1 |
p. S70-S71
|
artikel
|
| 152 |
Impact of COVID-19 on Breast clinic follow ups – a new way forward?
|
Norman, C.
|
|
|
138 |
S1 |
p. S110
|
artikel
|
| 153 |
Impact of Ki67 and progesterone receptor on PFS with cyclin-dependent kinase 4/6 inhibitors in HER2-negative advanced breast cancer: A real world mono-institutional experience
|
Palleschi, M.
|
|
|
138 |
S1 |
p. S66-S67
|
artikel
|
| 154 |
Impacts of omission of breast cancer surgery in older women with ER+ early breast cancer. A risk stratified analysis of survival and quality of life outcomes
|
Wyld, L.
|
|
|
138 |
S1 |
p. S6-S7
|
artikel
|
| 155 |
Implementation of a nurse-led wound care consultation after breast cancer surgery
|
Vandezande, L.
|
|
|
138 |
S1 |
p. S52-S53
|
artikel
|
| 156 |
Implication of atypical supraclavicular F18-fluorodeoxyglucose uptake in patients with breast cancer: Relationship between brown adipose tissue and TILs, PD-L1
|
Fujii, T.
|
|
|
138 |
S1 |
p. S94
|
artikel
|
| 157 |
Importance of intraoperatory surgical margin assessment for positive margin diagnosis in breast cancer-conserving surgery
|
Urdiain, A.Goikoetxea
|
|
|
138 |
S1 |
p. S49
|
artikel
|
| 158 |
Improved QTcF diagnostic using tele-cardiology
|
Fink, L.S.
|
|
|
138 |
S1 |
p. S67
|
artikel
|
| 159 |
Improvement of recurrent rates and survival in patients with primary breast cancer according to subtypes
|
Nakano, M.
|
|
|
138 |
S1 |
p. S21
|
artikel
|
| 160 |
Improving pain outcomes after breast cancer surgery using a novel psychoeducational intervention
|
Alwan, M.
|
|
|
138 |
S1 |
p. S53
|
artikel
|
| 161 |
Innovative magnetic tracers for sentinel node detection in primary breast cancer surgery and after neoadjuvant therapy
|
Rauš, K.
|
|
|
138 |
S1 |
p. S46-S47
|
artikel
|
| 162 |
Integration of genomic profiling and functional screening identifies potential driver somatic copy number alterations in triple-negative breast cancer
|
Xie, G.
|
|
|
138 |
S1 |
p. S74
|
artikel
|
| 163 |
Interaction of PAFAH and beta-catenin in BRCA1 mutant breast cancer
|
Liao, Y.
|
|
|
138 |
S1 |
p. S77
|
artikel
|
| 164 |
Internal audit of an Indian breast oncosurgery unit using EUSOMA guidelines
|
Gupta, S.
|
|
|
138 |
S1 |
p. S38
|
artikel
|
| 165 |
Interplay between the Pan-Tumor Suppressor miR-939-5p and the oncogenic lncRNA-HEIH dually curbs Hydrogen Sulphide and Nitric Oxide production in breast cancer cells
|
Nafea, H.
|
|
|
138 |
S1 |
p. S70
|
artikel
|
| 166 |
Is sentinel lymph node biopsy necessary in the setting of microinvasive DCIS?
|
Desai, K.
|
|
|
138 |
S1 |
p. S87
|
artikel
|
| 167 |
Is socioeconomic status a barrier for individual breast cancer awareness in developing countries?
|
Sarkar, A.Giri
|
|
|
138 |
S1 |
p. S81-S82
|
artikel
|
| 168 |
Knowledge attitude and practice of surgeons for breast conserving surgery: Results from an Indian cohort
|
Nair, N.
|
|
|
138 |
S1 |
p. S34
|
artikel
|
| 169 |
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study
|
Pelizzari, G.
|
|
|
138 |
S1 |
p. S63
|
artikel
|
| 170 |
Long-term prognosis is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status
|
Zetterlund, L.
|
|
|
138 |
S1 |
p. S22
|
artikel
|
| 171 |
Magnetic resonance imaging: Role in the response to neoadjuvant therapy of breast cancer
|
Surace, A.
|
|
|
138 |
S1 |
p. S85-S86
|
artikel
|
| 172 |
Magseed localisation for loco-regional breast and lymph node recurrences. Placement prior to chemotherapy allows focused removal of the initially diseased tissue
|
Benn, C.
|
|
|
138 |
S1 |
p. S46
|
artikel
|
| 173 |
Male breast cancer: A high volume centre experience
|
Combi, F.
|
|
|
138 |
S1 |
p. S40
|
artikel
|
| 174 |
Management of early breast cancer by trastuzumab biosimilar: Insights from observational drug utilization registry
|
Dwary, A.D.
|
|
|
138 |
S1 |
p. S57
|
artikel
|
| 175 |
Mantle cell lymphoma in the context of breast cancer
|
Vernadou, A.
|
|
|
138 |
S1 |
p. S60
|
artikel
|
| 176 |
Mesh-Pocket supported prepectoral implant-based breast reconstruction: Final results of a retrospective analysis
|
Paepke, S.
|
|
|
138 |
S1 |
p. S27-S28
|
artikel
|
| 177 |
Metachronous breast cancer: An observational study in a single institution
|
Lee, W.P.
|
|
|
138 |
S1 |
p. S20-S21
|
artikel
|
| 178 |
Metastatic breast cancer: A retrospective review
|
Boyle, S.
|
|
|
138 |
S1 |
p. S100
|
artikel
|
| 179 |
Micro-morphological regression patterns of tumors and lymph nodes following neoadjuvant chemotherapy for breast cancer with follow-up analysis: a new scoring system with implication into practice
|
Śniadecki, M.
|
|
|
138 |
S1 |
p. S75
|
artikel
|
| 180 |
Minimally Invasive Complete Response Assessment of the breast after neoadjuvant systemic therapy (MICRA trial): Interim analysis of a multicenter observational cohort study
|
Van Loevezijn, A.
|
|
|
138 |
S1 |
p. S9-S10
|
artikel
|
| 181 |
miR-486-5p and miR-17-5p: Novel Immunomodulatory Non-coding RNAs Drawn Downstream 3′-O-Acetylvitexin in Triple Negative Breast Cancer
|
Elkhouly, A.
|
|
|
138 |
S1 |
p. S70
|
artikel
|
| 182 |
Mobile health (mhealth) to improve quality of life in breast cancer survivors: study protocol for randomized controlled trial
|
Kaur, M.
|
|
|
138 |
S1 |
p. S91
|
artikel
|
| 183 |
Monitoring clinical patterns in early and advanced breast cancer in Europe through population-based cancer registries data
|
Giusti, F.
|
|
|
138 |
S1 |
p. S106
|
artikel
|
| 184 |
More precise mitotic count and estrogen/progesteron (ER/PR) scoring system impact on grading in pre- and post-neoadjuvant primary breast cancer: morphological, clinical and radiological assessment
|
Giacometti, C.
|
|
|
138 |
S1 |
p. S89-S90
|
artikel
|
| 185 |
MRI accuracy in each immunophenotype to evaluate axillary tumour load after neoadjuvant treatment
|
Vernet-Tomas, M.
|
|
|
138 |
S1 |
p. S88
|
artikel
|
| 186 |
Multicenter study to evaluate the efficacy and standardize radiofrequency ablation therapy for small breast carcinomas
|
Kinoshita, T.
|
|
|
138 |
S1 |
p. S25
|
artikel
|
| 187 |
Multidisciplinary breast cancer guideline in the Netherlands: Modular revisions aiming for improved personalized breast cancer care
|
Van Hoeve, J.
|
|
|
138 |
S1 |
p. S37
|
artikel
|
| 188 |
Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care during COVID-19 outbreak in North-Eastern Italy. When the going gets tough, the tough gets going!
|
Giacometti, C.
|
|
|
138 |
S1 |
p. S120
|
artikel
|
| 189 |
Multi-targeting antibody to control proliferation, metastasis and angiogenesis in mammary gland tumor
|
Vafaei, R.
|
|
|
138 |
S1 |
p. S71
|
artikel
|
| 190 |
Muscle quality is a prognostic factor for postoperative complications after DIEP-flap breast reconstruction
|
Sadok, N.
|
|
|
138 |
S1 |
p. S82-S83
|
artikel
|
| 191 |
Nationwide population-based study: Patterns of care in young breast cancer patients in the Netherlands
|
Maliko, N.
|
|
|
138 |
S1 |
p. S39
|
artikel
|
| 192 |
Neoadjuvant endocrine treatment and clinical outcome in ER positive breast cancer – a single UK cancer centre experience
|
Benafif, S.
|
|
|
138 |
S1 |
p. S124
|
artikel
|
| 193 |
Neutrophil to lymphocyte ratio (NLR) may predict survival and efficacy of eribulin in advanced breast cancer patients
|
Haruyama, Y.
|
|
|
138 |
S1 |
p. S64-S65
|
artikel
|
| 194 |
New germline RAD51D gene variant in the Mongol breast cancer patients
|
Molokov, A.
|
|
|
138 |
S1 |
p. S79-S80
|
artikel
|
| 195 |
New potential therapeutics based on natural polyphenol and SASP inhibitor combination for treating cutaneous sequelae following radiotherapy and chemotherapy in breast cancer patients
|
Rodriguez-Candela, M.
|
|
|
138 |
S1 |
p. S107-S108
|
artikel
|
| 196 |
Nine-year survival outcome of neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer (NeoALTTO, BIG 1-06): final analysis of a multicentre, open-label, phase 3 randomised clinical trial.
|
Nuciforo, P.
|
|
|
138 |
S1 |
p. S15-S16
|
artikel
|
| 197 |
Nipple sparing mastectomy (NSM) after surgical delay (SD) and prepectoral direct to implant (DTI) reconstruction with polyurethane prostheses: Preliminary results
|
Loreti, A.
|
|
|
138 |
S1 |
p. S50
|
artikel
|
| 198 |
Non-BRCA hereditary gene mutations in the Mongol breast cancer patients of Russia
|
Gervas, P.
|
|
|
138 |
S1 |
p. S78
|
artikel
|
| 199 |
Non-intervention vs. surgical interventions in (Low-Risk) Ductal Carcinoma In Situ: A DCIS multi-state model for decision analytics
|
Byng, D.
|
|
|
138 |
S1 |
p. S25
|
artikel
|
| 200 |
Nonradioactive surgical guidance with radiofrequency identification technology for locating nonpalpable breast lesions; Initial experiences of the RFID Localizer I Trial
|
Christenhusz, A.
|
|
|
138 |
S1 |
p. S117
|
artikel
|
| 201 |
Normative BREAST-Q data from a Dutch population-based cohort
|
Clarijs, M.
|
|
|
138 |
S1 |
p. S107
|
artikel
|
| 202 |
Omission of axillary dissection after neoadjuvant chemotherapy for node-positive primary breast cancer
|
Matsumoto, A.
|
|
|
138 |
S1 |
p. S29
|
artikel
|
| 203 |
Omitting completion axillary lymph node dissection after sentinel node micrometastases in breast cancer – first results from the Swedish prospective SENOMIC trial
|
Andersson, Y.
|
|
|
138 |
S1 |
p. S3
|
artikel
|
| 204 |
Oncological safety of oncoplastic breast conserving surgery- compare with conventional surgery
|
Kim, Y.
|
|
|
138 |
S1 |
p. S28
|
artikel
|
| 205 |
Oncoplastic breast-conserving surgery offers low local recurrence rates and excellent survival rates despite worse tumor characteristics
|
André, C.
|
|
|
138 |
S1 |
p. S28-S29
|
artikel
|
| 206 |
Optimal duration and effectiveness of neoadjuvant endocrine therapy in breast cancer – Retrospective series
|
Konsoulova-Kirova, A.
|
|
|
138 |
S1 |
p. S58
|
artikel
|
| 207 |
Optimization of wire-guided technique with bracketing reduces resection volumes in breast-conserving surgery for early breast cancer
|
Civil, Y.
|
|
|
138 |
S1 |
p. S31-S32
|
artikel
|
| 208 |
Organisational characteristics of informed decision-making implementation in mammography screening programmes in 28 European countries
|
Ritchie, D.
|
|
|
138 |
S1 |
p. S99
|
artikel
|
| 209 |
Outcomes of breast cancer patients with nodal micrometastasis treated with sentinel lymph node biopsy versus axillary lymph node dissection
|
Kusumawidjaja, G.
|
|
|
138 |
S1 |
p. S45
|
artikel
|
| 210 |
Outcomes of Magseed localisation of non-palpable breast lesions in a large university hospital
|
Gaber, A.
|
|
|
138 |
S1 |
p. S41-S42
|
artikel
|
| 211 |
P53 and axillary tumor burden in breast cancer
|
Nicolau, P.
|
|
|
138 |
S1 |
p. S35-S36
|
artikel
|
| 212 |
Panel-guided personalized medicine in metastatic breast and gynecological cancer: First experiences at the Comprehensive Cancer Centre Munich and clinical relevant changes over time
|
Sultova, E.
|
|
|
138 |
S1 |
p. S4
|
artikel
|
| 213 |
Pathological complete response to neoadjuvant trastuzumab and pertuzumab therapy is dependent on HER2/CEP17 ratio in HER2-positive breast cancer
|
Jung, S.
|
|
|
138 |
S1 |
p. S59
|
artikel
|
| 214 |
Patient-assisted vs standard compression mode in mammography screening: A randomized clinical trial
|
Rivera, E.N. Arenas
|
|
|
138 |
S1 |
p. S74
|
artikel
|
| 215 |
Patient-informed learning to assist development of personalised treatment care plans for breast cancer patients and survivors
|
Kearns, C.
|
|
|
138 |
S1 |
p. S69
|
artikel
|
| 216 |
Patient-reported healthcare utilization among Medicare beneficiaries with HR-positive, HER2-negative early breast cancer
|
Calip, G.S.
|
|
|
138 |
S1 |
p. S108-S109
|
artikel
|
| 217 |
Patient Reported Outcome and cosmetic evaluation following implant-based breast-reconstruction with a titanized polypropylene mesh: A prospective clinical study in 269 patients
|
Thill, M.
|
|
|
138 |
S1 |
p. S30
|
artikel
|
| 218 |
Patient-reported outcome measures used for reporting late effects in postmenopausal breast cancer survivors and compared to general symptoms in a Danish female age matched population
|
Nielsen, A.W.M.
|
|
|
138 |
S1 |
p. S90
|
artikel
|
| 219 |
Patient Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) for patients undergoing radiotherapy for breast cancer: A single-center prospective registry experience
|
Bhangoo, R.
|
|
|
138 |
S1 |
p. S114
|
artikel
|
| 220 |
Patients’ experience with mammography and attitude towards targeted breast ultrasound as initial imaging technique for the evaluation of focal breast complaints
|
Siebers, C.
|
|
|
138 |
S1 |
p. S98
|
artikel
|
| 221 |
Patients reported outcomes (PRO) in breast conserving treatment
|
Anchuelo, J.
|
|
|
138 |
S1 |
p. S112
|
artikel
|
| 222 |
Patients’ willingness to travel further to have their cancer surgery at a Centre of Excellence
|
Cairney-Hill, J.
|
|
|
138 |
S1 |
p. S104
|
artikel
|
| 223 |
Patterns of treatment and outcome of ductal carcinoma in situ for population-based screened women
|
Luiten, J.
|
|
|
138 |
S1 |
p. S97
|
artikel
|
| 224 |
Patterns of treatment and outcomes in real world elderly patients with metastatic oestrogen receptor positive (ER+) breast cancer receiving the CDK4/6 inhibitor Palbociclib and endocrine therapy
|
Skrobo, D.
|
|
|
138 |
S1 |
p. S102-S103
|
artikel
|
| 225 |
PD-L1 and HSP-70 molecules are part of immunosupressive environment in the deep layer of the lymphocyte predominant breast cancer (LPBC)
|
Peterko, A.Car
|
|
|
138 |
S1 |
p. S22-S23
|
artikel
|
| 226 |
Peer Review Policy for the European Journal of Cancer (EJC)
|
|
|
|
138 |
S1 |
p. iv
|
artikel
|
| 227 |
PIK3CA mutations and predicting the therapeutic effects of neoadjuvant chemotherapy in primary breast cancer
|
Sato, A.
|
|
|
138 |
S1 |
p. S72
|
artikel
|
| 228 |
Plasma markers showing differential baseline expression in relapsing versus non-relapsing patients with hormone sensitive breast tumors
|
Hatse, S.
|
|
|
138 |
S1 |
p. S73
|
artikel
|
| 229 |
Population trends in lobular carcinoma of the breast: The Ontario experience
|
Findlay-Shirras, L.
|
|
|
138 |
S1 |
p. S43-S44
|
artikel
|
| 230 |
Positive correlation between high breast cancer incidence and ancestry in Colombian population
|
Ordoñez, Y.T. Zambrano
|
|
|
138 |
S1 |
p. S111
|
artikel
|
| 231 |
Predicting lymph node metastases for biopsy diagnosis ductal carcinoma in situ: The DCIS-met model
|
Meurs, C.
|
|
|
138 |
S1 |
p. S31
|
artikel
|
| 232 |
Predicting postoperative complications in older patients with breast cancer
|
Lemij, A.
|
|
|
138 |
S1 |
p. S32
|
artikel
|
| 233 |
Predictive factors involved in determining response to neoadjuvant chemotherapy in breast cancer and impact of response on 5 years disease free survival and overall survival
|
Rehman, B.
|
|
|
138 |
S1 |
p. S40
|
artikel
|
| 234 |
Predictors of efficacy in patients (pts) with hormone receptor–positive/ human epidermal growth factor receptor 2–negative advanced breast cancer (HR+/HER2− ABC): Subgroup analyses of PALOMA-3
|
Rugo, H.
|
|
|
138 |
S1 |
p. S7-S8
|
artikel
|
| 235 |
Predictors of seroma formation after breast cancer surgery
|
Vos, H.
|
|
|
138 |
S1 |
p. S39
|
artikel
|
| 236 |
Predictors of surgical margin involvement in breast cancer surgery
|
Urdiain, A.Goikoetxea
|
|
|
138 |
S1 |
p. S24
|
artikel
|
| 237 |
Preoperative systemic treatment in breast cancer patients. Does the site of response matter?
|
Esgueva, A.
|
|
|
138 |
S1 |
p. S91-S92
|
artikel
|
| 238 |
Prevalence of germline BRCA pathogenic variants in a monoinstitutional cohort of patients with triple negative breast cancer
|
De Matteis, E.
|
|
|
138 |
S1 |
p. S79
|
artikel
|
| 239 |
Primary endocrine treatment for older women with early-stage hormone receptor-positive breast cancer. Real-World experience from a single UK cancer centre
|
Rapti, C.
|
|
|
138 |
S1 |
p. S105
|
artikel
|
| 240 |
Prognosis according to the timing of recurrence in breast cancer
|
Jung, S.
|
|
|
138 |
S1 |
p. S23
|
artikel
|
| 241 |
Prognostic role of breast pathologic complete response after neoadjuvant chemotherapy in node-positive breast cancer patients
|
Woo, J.
|
|
|
138 |
S1 |
p. S23
|
artikel
|
| 242 |
Prognostic utility of androgen receptor signaling pathway in invasive breast cancer
|
Kurozumi, S.
|
|
|
138 |
S1 |
p. S74
|
artikel
|
| 243 |
Project PRIMO – Combining Patient Derived Breast Cancer Microtumors and DigiWest protein signaling pathway profiling for therapeutic response prediction
|
Anderle, N.
|
|
|
138 |
S1 |
p. S72
|
artikel
|
| 244 |
Prone, stereotactic, vacuum-assisted breast biopsy
|
Jánvári, M.
|
|
|
138 |
S1 |
p. S86
|
artikel
|
| 245 |
Prospectively registered acute toxicity in breast cancer patients undergoing adjuvant intensity modulated proton therapy
|
Verhoeven, K.
|
|
|
138 |
S1 |
p. S85
|
artikel
|
| 246 |
Psycho-social assessment of post-surgery outcomes after breast reconstruction surgery
|
Busheri, L.
|
|
|
138 |
S1 |
p. S25
|
artikel
|
| 247 |
Psychosocial outcomes following contralateral prophylactic mastectomy in women with unilateral, nonhereditary breast cancer
|
Lim, D.
|
|
|
138 |
S1 |
p. S44-S45
|
artikel
|
| 248 |
Pyrotinib in HER2-Positive local advanced or metastatic breast cancer patients: Results from a retrospective study in real-world setting
|
Wang, Q.
|
|
|
138 |
S1 |
p. S58
|
artikel
|
| 249 |
Quality of life improvement and pain reduction in implant-based breast reconstruction by means of selective pectoralis major muscle denervation
|
Bernini, M.
|
|
|
138 |
S1 |
p. S26
|
artikel
|
| 250 |
Quality of life in postmenopausal breast cancer patients with localized disease after 5 years of endocrine treatment: A prospective study
|
Arraras, J.I.
|
|
|
138 |
S1 |
p. S61
|
artikel
|
| 251 |
Quality of life of cancer patients at palliative care units in developing countries – systematic review of the published literature
|
Gayatri, D.
|
|
|
138 |
S1 |
p. S123
|
artikel
|
| 252 |
Quality of life outcomes following breast surgery in older women with operable breast cancer: Analysis of the Bridging the Age Gap study
|
Morgan, J.
|
|
|
138 |
S1 |
p. S29-S30
|
artikel
|
| 253 |
Quality of life (QL) in elderly breast cancer survivors. Effects of surgery. Global QL determinants
|
Arraras, J.I.
|
|
|
138 |
S1 |
p. S58
|
artikel
|
| 254 |
Quality of life (QoL) post surgical treatment of breast carcinoma: A prospective study
|
Palma, E.
|
|
|
138 |
S1 |
p. S83
|
artikel
|
| 255 |
Radioactive seed versus wire-guided localization for ductal carcinoma in situ of the breast: Comparable resection margins
|
Agahozo, M.C.
|
|
|
138 |
S1 |
p. S31
|
artikel
|
| 256 |
Radio-Frequency Identification (RFID) Tags for localisation of impalpable breast cancers results in reduced waiting times for patients on day of surgery
|
Bell, A.
|
|
|
138 |
S1 |
p. S118
|
artikel
|
| 257 |
Radiomics and Machine Learning with DWI for breast cancer diagnosis: Comparison with dynamic contrast enhanced and multiparametric MRI
|
Naranjo, I.Daimiel
|
|
|
138 |
S1 |
p. S13-S14
|
artikel
|
| 258 |
Realising true day-case breast surgery: A review of factors influencing same-day discharge (SDD)
|
Chouari, T.
|
|
|
138 |
S1 |
p. S50
|
artikel
|
| 259 |
Real-life use of 21-gene signature: A retrospective analysis of 46 cases from private practice
|
Marty, C.Bernard
|
|
|
138 |
S1 |
p. S56
|
artikel
|
| 260 |
Real-time non-invasive chemoresistance profiling of circulating tumor associated cells in breast cancers to determine resistance towards mitotic inhibitors
|
Srinivasan, A.
|
|
|
138 |
S1 |
p. S76-S77
|
artikel
|
| 261 |
Real-world analysis of patients’ clinical and geriatric characteristics aged ≥70 years with advanced breast cancer receiving palbociclib with endocrine therapy in the French cohort PALOMAGE
|
Brain, E.
|
|
|
138 |
S1 |
p. S20
|
artikel
|
| 262 |
Real-World data of triplet combination of trastuzumab, lapatinib and chemotherapy in HER2-positive metastatic breast cancer: A multicenter retrospective study
|
Li, Y.
|
|
|
138 |
S1 |
p. S66
|
artikel
|
| 263 |
Real world evidence of palbociclib use in metastatic hormone positive HER negative metastatic breast cancer in Indian population
|
Agrawal, C.
|
|
|
138 |
S1 |
p. S103
|
artikel
|
| 264 |
Real world treatment patterns and clinical outcomes associated with palbociclib combination therapy in nine european countries: Results from the IRIS study
|
Mycock, K.
|
|
|
138 |
S1 |
p. S103-S104
|
artikel
|
| 265 |
Recommendations from the European Commission Initiative on Breast Cancer on multigene tests to guide the use of adjuvant chemotherapy in patients who have hormone receptor positive, HER-2 negative, lymph node negative or up to 3 lymph nodes positive invasive breast cancer
|
Rossi, P.Giorgi
|
|
|
138 |
S1 |
p. S12-S13
|
artikel
|
| 266 |
Reconsidering the management of palpable DCIS: a single institution audit
|
Nair, N.
|
|
|
138 |
S1 |
p. S87-S88
|
artikel
|
| 267 |
Reduction of Serious Adverse Events (SAE) under palbociclib treatment in patients using an interactive eHealth system
|
Schmidt, M.
|
|
|
138 |
S1 |
p. S68
|
artikel
|
| 268 |
Relationship between FDG uptake and platelet/lymphocyte ratio in patients with breast invasive ductal cancer
|
Endo, M.
|
|
|
138 |
S1 |
p. S94
|
artikel
|
| 269 |
Relationship between VEGF-A and PD-L1 expression in primary breast cancer
|
Nishiki, E.
|
|
|
138 |
S1 |
p. S75-S76
|
artikel
|
| 270 |
Results of locoregional radiotherapy or axillary dissection in breast cancer with pN0(i+) and pN1mi nodal disease
|
Altinok, A.
|
|
|
138 |
S1 |
p. S85
|
artikel
|
| 271 |
Retrospective analysis of survival of breast cancer patients with ipsilateral supraclavicular lymph node metastasis
|
Xianfu, S.
|
|
|
138 |
S1 |
p. S38
|
artikel
|
| 272 |
Risk of contralateral breast cancer and ovarian cancer in BRCA1 founder mutation (5382insC or 4154delA) carriers with primary breast cancer
|
Loza, P.
|
|
|
138 |
S1 |
p. S48
|
artikel
|
| 273 |
Risk of subsequent in situ and invasive lesions after a primary diagnosis of ductal carcinoma in situ with follow-up time up to 28 years
|
Van Seijen, M.
|
|
|
138 |
S1 |
p. S10-S11
|
artikel
|
| 274 |
Role of immunohistochemical determination of Bcl-2 and p53 expression in identifying hormone receptors positive/Her 2 negative (Luminal-like) high-risk breast cancer patients
|
Dajti, G.
|
|
|
138 |
S1 |
p. S94-S95
|
artikel
|
| 275 |
Role of Ultrasound Elastography in characterization of breast lesions: Does it really count?
|
Sharma, S.
|
|
|
138 |
S1 |
p. S119
|
artikel
|
| 276 |
Safety of pre-pectoral breast reconstruction followed by post mastectomy radiotherapy
|
Bernini, M.
|
|
|
138 |
S1 |
p. S10
|
artikel
|
| 277 |
Salivary metabolomics with artificial intelligence-based methods for breast cancer detection and subtype prediction
|
Murata, T.
|
|
|
138 |
S1 |
p. S18
|
artikel
|
| 278 |
Scalp cooling system to prevent alopecia: Effectiveness, psychological effects and feasibility
|
Guglielmi, A.
|
|
|
138 |
S1 |
p. S90
|
artikel
|
| 279 |
Screen-detected breast cancers have different tumor biology and better prognosis compared to interval breast cancers
|
Cardozo, J.Lopes
|
|
|
138 |
S1 |
p. S9
|
artikel
|
| 280 |
Selective axillary dissection after axillary reverse mapping in node positive breast cancer patients to prevent breast cancer related lymphedema. The issue of safety
|
Gennaro, M.
|
|
|
138 |
S1 |
p. S38-S39
|
artikel
|
| 281 |
Sense of coherence as predictor of quality of life in early breast cancer patients
|
Hakamies-Blomqvst, L.
|
|
|
138 |
S1 |
p. S18
|
artikel
|
| 282 |
SentiDose Trial: Optimizing dose and injection timing in magnetic sentinel node detection for early breast cancer
|
Karakatsanis, A.
|
|
|
138 |
S1 |
p. S45
|
artikel
|
| 283 |
Sentinel lymph node biopsy in early breast cancer: Experience from a tertiary care facility in India
|
Goel, A.K.
|
|
|
138 |
S1 |
p. S115
|
artikel
|
| 284 |
Sentinel node after NeoAdjuvancy in node-positive breast cancer. SANA multicentric study
|
Rosello, I.Vives
|
|
|
138 |
S1 |
p. S114
|
artikel
|
| 285 |
Short-term outcome and complications rate after immediate breast reconstruction with implants and acellular dermis
|
Bjelic-Radisic, V.
|
|
|
138 |
S1 |
p. S44
|
artikel
|
| 286 |
Should chemotherapy in neoadjuvant setting in node positive breast cancers be guided by biology over magnitude of tumour burden?
|
Provenzano, E.
|
|
|
138 |
S1 |
p. S56
|
artikel
|
| 287 |
Single pre-operative radiation therapy – with delayed surgery for low risk breast cancer (SPORT-DS)
|
Lavigne, D.
|
|
|
138 |
S1 |
p. S112-S113
|
artikel
|
| 288 |
Size discrepancy of residual tumor between post chemotherapy sonography and on post excision histopathology after Neo adjuvant chemotherapy and its impact on 5 years disease free survival
|
Khanum, N.
|
|
|
138 |
S1 |
p. S41
|
artikel
|
| 289 |
SPIO-guided Sentinel Lymph Node Biopsy (SLNB) in early Breast Cancer – first monoinstitutional data and perspectives
|
Paepke, S.
|
|
|
138 |
S1 |
p. S27
|
artikel
|
| 290 |
Standard treatment in very old breast cancer patients. Recommended or not recommended?
|
Bortolini, M.
|
|
|
138 |
S1 |
p. S109
|
artikel
|
| 291 |
Surgery of the primary tumour in women with metastatic breast cancer at diagnosis in England and Wales – how do treatment rates vary at an individual and regional level?
|
Miller, K.
|
|
|
138 |
S1 |
p. S116-S117
|
artikel
|
| 292 |
Surgical margin involvement increases distant recurrence, not just local recurrence
|
Michael, S.
|
|
|
138 |
S1 |
p. S41
|
artikel
|
| 293 |
Survival benefit of surveillance for postoperative metastasis in breast cancer patients
|
Jung, S.M.
|
|
|
138 |
S1 |
p. S112
|
artikel
|
| 294 |
Symptomatic presentation and involved margins lead to Ductal Cancer In Situ recurrence
|
Michael, S.
|
|
|
138 |
S1 |
p. S46
|
artikel
|
| 295 |
Symptom talk during clinic visits for treatment of breast cancer: Do we get an accurate picture?
|
Mooney, K.
|
|
|
138 |
S1 |
p. S54
|
artikel
|
| 296 |
Systematic review of impact of intra-operative ultrasound in breast conserving surgery in early breast cancer
|
Tin, S.M.M.
|
|
|
138 |
S1 |
p. S102
|
artikel
|
| 297 |
Table of Contents
|
|
|
|
138 |
S1 |
p. v-vi
|
artikel
|
| 298 |
Tailored axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer patients is safe: 3-year follow-up of the MARI protocol
|
Van Loevezijn, A.
|
|
|
138 |
S1 |
p. S3-S4
|
artikel
|
| 299 |
The Age Gap study: A prospective observational cohort study to determine the relationship between age, tumour stage and biology in older women with early breast cancer
|
Lim, M.
|
|
|
138 |
S1 |
p. S122-S123
|
artikel
|
| 300 |
The COVID-19 outbreak may be associated to a reduced level of care for breast cancer. A comparative study with the pre-COVID era in an Italian Breast Unit
|
Fancellu, A.
|
|
|
138 |
S1 |
p. S16-S17
|
artikel
|
| 301 |
The effect of a chamomile compound on pain and heaviness in breast cancer patients with lymphedema: A double-blind and randomized controlled trial
|
Sheikhi-Mobarakeh, Z.
|
|
|
138 |
S1 |
p. S54
|
artikel
|
| 302 |
The effect of a decision aid for breast cancer patients deciding on their radiation treatment
|
Raphael, D.
|
|
|
138 |
S1 |
p. S84-S85
|
artikel
|
| 303 |
The effect of postoperative complications on survival and recurrence after surgery for breast cancer: A systematic review and meta-analysis
|
Edwards, J.
|
|
|
138 |
S1 |
p. S108
|
artikel
|
| 304 |
The effect of Scalp-Cooling System on the prevention of alopecia after chemotherapy
|
Maseki, H.
|
|
|
138 |
S1 |
p. S53
|
artikel
|
| 305 |
The effects of lifestyle modification, including dietary and physical activity interventions, on Anthropometric indices and Quality of life of patients with breast cancer: A systematic review and meta-analysis of clinical trials
|
Razmpoosh, E.
|
|
|
138 |
S1 |
p. S82
|
artikel
|
| 306 |
The enduring rise of the contralateral prophylactic mastectomy: Population trends in Ontario, Canada
|
Findlay-Shirras, L.
|
|
|
138 |
S1 |
p. S44
|
artikel
|
| 307 |
The gene expression profile in clinically node negative T1–2 breast cancer patients: Its additional value in case of sentinel lymph node biopsy is not performed
|
Colier, E.
|
|
|
138 |
S1 |
p. S61
|
artikel
|
| 308 |
The generalisability of randomised clinical trials: An interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer
|
De Boniface, J.
|
|
|
138 |
S1 |
p. S3
|
artikel
|
| 309 |
The global prevalence of anxiety among advanced breast cancer patients: A systematic review and meta-analysis
|
Karibayeva, I.
|
|
|
138 |
S1 |
p. S101-S102
|
artikel
|
| 310 |
The impact of advanced or metastatic breast cancer or its treatment on productivity, energy, and physical activity among palbociclib participants of the MADELINE study
|
Richardson, D.
|
|
|
138 |
S1 |
p. S100-S101
|
artikel
|
| 311 |
The impact of radiotherapy on patient-reported outcomes of immediate implant-based breast reconstruction: Results of a prospective multicentre cohort study
|
Sewart, E.
|
|
|
138 |
S1 |
p. S35
|
artikel
|
| 312 |
The impact of the COVID-19 pandemic on quality of life, physical and psychosocial wellbeing in breast cancer patients – a prospective, multicenter cohort study
|
Bargon, C.
|
|
|
138 |
S1 |
p. S17
|
artikel
|
| 313 |
The prevalence of depression symptoms among advanced breast cancer patients: A systematic review and meta-analysis
|
Karibayeva, I.
|
|
|
138 |
S1 |
p. S101
|
artikel
|
| 314 |
The psychosexual effects of risk reducing bilateral salpingooophorectomy in female BRCA1/2 mutation carriers: A systematic review
|
Hickey, I.
|
|
|
138 |
S1 |
p. S110
|
artikel
|
| 315 |
The relative eosinophil count in breast cancer as an emerging prognostic biomarker
|
Onesti, C.E.
|
|
|
138 |
S1 |
p. S86-S87
|
artikel
|
| 316 |
The REMAR (Rhein-Main-Registry)-Study: Prospective evaluation of oncotype DX® Assay in Addition to Ki-67 for adjuvant treatment decisions in early breast cancer
|
Thill, M.
|
|
|
138 |
S1 |
p. S92-S93
|
artikel
|
| 317 |
The risk of cardiovascular disease in irradiated breast cancer patients: The role of cardiac calcifications and adjuvant treatment
|
Gal, R.
|
|
|
138 |
S1 |
p. S6
|
artikel
|
| 318 |
The risk of colorectal cancer associated with BRCA 1 and/or BRCA 2 mutation carriers: systematic review and meta-analysis
|
Cullinane, C.
|
|
|
138 |
S1 |
p. S80
|
artikel
|
| 319 |
The role of cryoablation in patients with metastatic breast cancer at the time of presentation
|
Fancellu, A.
|
|
|
138 |
S1 |
p. S48
|
artikel
|
| 320 |
The survival outcomes for the subsequent therapy after treatment with trastuzumab emtansine in human epidermal growth factor receptor 2-positive metastatic breast cancer patients
|
Watanuki, R.
|
|
|
138 |
S1 |
p. S62
|
artikel
|
| 321 |
The value of removing more than one sentinel node in breast cancer
|
Cardozo, J.Lopes
|
|
|
138 |
S1 |
p. S24
|
artikel
|
| 322 |
The value of shear-wave elastography for prediction of tumor-infiltrating lymphocytes in patients with breast cancer
|
Bae, S.J.
|
|
|
138 |
S1 |
p. S103
|
artikel
|
| 323 |
The value of uPA and PAI-1 levels in triple negative breast cancer
|
Sobocan, M.
|
|
|
138 |
S1 |
p. S73-S74
|
artikel
|
| 324 |
Time to first health care contact, referral pathways and stage at presentation – the experience from four South African breast units
|
Pothas, C.
|
|
|
138 |
S1 |
p. S69
|
artikel
|
| 325 |
Title Page
|
|
|
|
138 |
S1 |
p. i
|
artikel
|
| 326 |
Traumatic fat necrosis of the breast: a review of the spectrum of appearances of the ‘great mimicker’ of breast carcinoma
|
Sweeney, L.
|
|
|
138 |
S1 |
p. S121
|
artikel
|
| 327 |
Treatment efficacy and predictors of durable response to capecitabine monotherapy in advanced breast cancer: Real-world evidence from a large single-centre cohort
|
Thijssen, S.
|
|
|
138 |
S1 |
p. S65-S66
|
artikel
|
| 328 |
Trends in incidence, mortality, survival and treatment of primary invasive breast cancer in the Netherlands for women diagnosed between 1989–2017
|
van der Meer, D.J.
|
|
|
138 |
S1 |
p. S5
|
artikel
|
| 329 |
Tumor-Infiltrating Lymphocytes: Predictive changes in tumor size after neoadjuvant treatment
|
Fraile, J.Jimeno
|
|
|
138 |
S1 |
p. S60
|
artikel
|
| 330 |
Tumor-stroma ratio is associated with Miller-Payne and pathological response to neoadjuvant chemotherapy in HER2-negative early breast cancer
|
Hagenaars, S.
|
|
|
138 |
S1 |
p. S106
|
artikel
|
| 331 |
Unintended bias in clinical trials: The prevalence of entry criteria that exclude patients with invasive lobular carcinoma from metastatic breast cancer trials
|
Abel, M.K.
|
|
|
138 |
S1 |
p. S69-S70
|
artikel
|
| 332 |
Updated results of the MINDACT trial: 70-gene signature to guide de-escalation of chemotherapy in early breast cancer
|
Rutgers, E.J.T.
|
|
|
138 |
S1 |
p. S14-S15
|
artikel
|
| 333 |
Usefulness of locoregional nerve blocks in breast surgery. A comparative study
|
Fancellu, A.
|
|
|
138 |
S1 |
p. S37
|
artikel
|
| 334 |
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement for Aromatase Inhibitors-related Arthralgia Management (AIA): A prospective phase II trial (NCT04161833)
|
Desideri, I.
|
|
|
138 |
S1 |
p. S53
|
artikel
|
| 335 |
Use of Hologic LOCalizerTM radiofrequency identification (RFID) tags to localise impalpable breast lesions and axillary nodes: Experience of the first 150 cases in a UK breast unit
|
Bell, A.
|
|
|
138 |
S1 |
p. S118-S119
|
artikel
|
| 336 |
Use of indocyanine green (ICG) alone as a tracer for sentinel lymph node detection after neoadjuvant chemotherapy in breast cancer patients
|
Cattin, F.
|
|
|
138 |
S1 |
p. S65
|
artikel
|
| 337 |
Use of multi gene-panel testing to detect hereditary breast cancer gene variants in patients attending to a breast cancer clinic, Peradeniya, Sri Lanka
|
Yatawara, L.
|
|
|
138 |
S1 |
p. S80
|
artikel
|
| 338 |
Use of oral complementary-alternative medicine (OCAM) and fatigue among early breast cancer (BC) patients (pts)
|
Djehal, N.
|
|
|
138 |
S1 |
p. S92
|
artikel
|
| 339 |
Vacuum intraoperative specimen mammography: A novel technique
|
Baù, M.G.
|
|
|
138 |
S1 |
p. S23
|
artikel
|
| 340 |
Variation and efficacy of scalp cooling in Dutch hospitals among >5000 breast cancer patients
|
Van Den Hurk, C.
|
|
|
138 |
S1 |
p. S54-S55
|
artikel
|
| 341 |
Variation in the rates of surgical treatment of older women with operable breast cancer between UK breast units: Analysis of the Bridging the Age Gap Study
|
Morgan, J.
|
|
|
138 |
S1 |
p. S29
|
artikel
|
| 342 |
Versatility, clinical outcomes and mammographic follow-up of Chest Wall Perforator Flaps (CWPF): A single-centre experience
|
Seddon, T.
|
|
|
138 |
S1 |
p. S37-S38
|
artikel
|
| 343 |
Visual versus automatic measurement of mammographic breast density (MBD)
|
Izquierdo, M.
|
|
|
138 |
S1 |
p. S120
|
artikel
|
| 344 |
What signals cancer survivorship when revealed during the job application process to employers?
|
Sharipova, A.
|
|
|
138 |
S1 |
p. S92
|
artikel
|
| 345 |
Which are the predictive factors for the status of resection margins in breast conserving surgery and how they influence the overall survival and local recurrence?
|
Georgescu, R.
|
|
|
138 |
S1 |
p. S33-S34
|
artikel
|
| 346 |
Women diagnosed with Ductal Carcinoma In Situ (DCIS) and healthcare providers’ views on active surveillance for DCIS. Results from focus groups and in-depth interviews
|
Engelhardt, E.
|
|
|
138 |
S1 |
p. S36
|
artikel
|
| 347 |
Young age as an independent prognostic factor in breast cancer
|
Georgescu, R.
|
|
|
138 |
S1 |
p. S42
|
artikel
|
| 348 |
YouTube as a source of information for breast-examination for patients and healthcare professionals: content, quality and reliability
|
Rangarajan, K.
|
|
|
138 |
S1 |
p. S100
|
artikel
|
Tijdschrift beschrijving